[Intima-media thickness and carotidofemoral plaques for cardiovascular risk stratification]

Andreas Erdmann1, Marco Fresa1, Giacomo Buso1

  • 1Service d'angiologie, Département coeur-vaisseaux, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|December 6, 2019
PubMed

Insights

Ultrasound measurement of intima-media thickness and atheroma can detect hidden cardiovascular disease risks. This method offers a valuable tool for improving cardiovascular risk assessment beyond traditional factors.

Area of Science:

  • Cardiology
  • Vascular Ultrasound
  • Preventive Medicine

Background:

  • Cardiovascular diseases remain a leading cause of death globally.
  • Traditional risk factors inadequately predict cardiovascular events in ~30% of cases.
  • Advanced imaging may identify undetected cardiovascular risks.

Purpose of the Study:

  • To evaluate the utility of ultrasound for measuring intima-media thickness.
  • To assess the detection of atheroma in carotid and femoral bifurcations.
  • To determine the value of these ultrasound parameters in predicting cardiovascular risk.

Main Methods:

  • Utilized ultrasound imaging.
  • Measured intima-media thickness (IMT) of arterial walls.
  • Detected atheromatous plaques in carotid and femoral arteries.

Main Results:

  • Intima-media thickness and atheroma detection by ultrasound show potential.
  • These ultrasound markers may offer improved cardiovascular risk prediction.
  • The study assesses the clinical value of these non-invasive measurements.

Conclusions:

  • Ultrasound assessment of IMT and atheroma is a promising approach.
  • This method could enhance cardiovascular risk stratification.
  • Further research can validate its role in preventive cardiology.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
716
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
335
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
403
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
285
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
822
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
319